Vaccinex announces exercise of warrants for $6.2M in gross proceeds
PremiumThe FlyVaccinex announces exercise of warrants for $6.2M in gross proceeds
2M ago
Vaccinex Director Chrystyna Bedrij Stecyk Abruptly Resigns
Premium
Company Announcements
Vaccinex Director Chrystyna Bedrij Stecyk Abruptly Resigns
2M ago
Vaccinex Provides Update on Alzheimer’s Treatment Trial
Premium
Company Announcements
Vaccinex Provides Update on Alzheimer’s Treatment Trial
3M ago
Vaccinex reports data for SIGNAL-AD Phase 1b/2 trial of pepinemab
PremiumThe FlyVaccinex reports data for SIGNAL-AD Phase 1b/2 trial of pepinemab
3M ago
Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab
Premium
The Fly
Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab
4M ago
Vaccinex files to sell 490,509 shares of common stock for holders
Premium
The Fly
Vaccinex files to sell 490,509 shares of common stock for holders
5M ago
Vaccinex trading resumes
PremiumThe FlyVaccinex trading resumes
6M ago
Vaccinex trading halted, volatility trading pause
Premium
The Fly
Vaccinex trading halted, volatility trading pause
6M ago
Vaccinex reports Q1 EPS ($2.94) vs. ($20.89) last year
Premium
The Fly
Vaccinex reports Q1 EPS ($2.94) vs. ($20.89) last year
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100